| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 05/15/2003 | CA2465186A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram |
| 05/15/2003 | CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 05/14/2003 | EP0906253B1 Supercritical hydrogenation |
| 05/14/2003 | CN1418210A Carbocyclik side chain containing, N-substituted Metalloprotease inhibitors |
| 05/14/2003 | CN1418209A Carbocyclic side chain containing metalloprotease inhibitors |
| 05/14/2003 | CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
| 05/14/2003 | CN1416953A Double-function catalyst for synthesizing cyclic carbonate and methyl carbonate |
| 05/14/2003 | CN1416952A High-activity catalyst for synthesizing cyclic carbonate in mild condition |
| 05/13/2003 | US6562967 Drug screening; purity |
| 05/13/2003 | US6562966 Combining a racemic or a diastereomeric mixture of a chiral substrate with a nucleophile, in the presence of a chiral non-racemic catalyst |
| 05/08/2003 | WO2003037885A1 Fluorosulfonyl compounds and process for production of compounds derived therefrom |
| 05/08/2003 | WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors |
| 05/08/2003 | WO2003037845A1 Compositions for treating acne comprising phytandiol amine |
| 05/08/2003 | WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 05/08/2003 | US20030088114 Kinetic resolution method |
| 05/08/2003 | US20030088113 From compounds such as 1-(benzyloxy)-6-bromo-3-(1,4-dioxaspiro(4.5)dec-8-yl)-2 -oxabicyclo(2.2.2)octan -5-one |
| 05/08/2003 | US20030087945 Sulfonylaminocarboxylic acids |
| 05/08/2003 | US20030087882 Antiinflammatory agents |
| 05/08/2003 | US20030087162 New electrolytes and lithium ion batterry using the same |
| 05/07/2003 | EP1308438A1 3-substituted urea derivatives and medicinal use thereof |
| 05/07/2003 | EP1308436A1 Calcium receptor antagonists |
| 05/07/2003 | EP1307460A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 05/07/2003 | EP1307441A1 1,3-dioxolanes with antitussive activity |
| 05/07/2003 | EP1307440A1 2,2-disubstituted 1,3-dioxolanes as antitussive agents |
| 05/07/2003 | EP1307436A1 Process for the preparation of baccatin iii derivatives |
| 05/07/2003 | EP0940387B1 Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same |
| 05/07/2003 | EP0799219B1 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 05/07/2003 | CN1415619A Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage |
| 05/07/2003 | CN1415618A Compound possessing function for preventing and curing thrombus disease, its pharmacy compsn. and usage in medication |
| 05/07/2003 | CN1415617A Compound possessing function for preventing and curing atherosclerosis and its application in biologic pharmacological science |
| 05/07/2003 | CN1415416A High activity catalyzer utilized to synthesize cyclic carbonate |
| 05/06/2003 | US6559347 Diels-adler adducts of epoxybutene and epoxybutene derivatives |
| 05/06/2003 | US6559310 Aryl borates |
| 05/06/2003 | US6559179 Tinvention relates to the use of compounds as inhibitors of the fatty acid synthase FabH. |
| 05/06/2003 | US6559176 A method for regulating the activity of an autoinducer-2 receptor comprising contacting an autoinducer-2 receptor with an AI-2 agonist or antagonist compound. |
| 05/02/2003 | EP1306362A1 Processes for the preparation of fluorinated acyl fluorides and fluorinated vinyl ethers |
| 05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 05/02/2003 | EP1305270A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 05/02/2003 | EP1121351A4 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 05/02/2003 | EP1056739B1 Novel cyclic pro-perfumes having modifiable fragrance raw material alcohol release rate |
| 05/02/2003 | EP1025082B1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 05/01/2003 | WO2003035637A1 5-methylene-1,3-dioxolan-4-one derivatives, process for their production, polymers of the derivatives, resist compositions, and pattern formation process |
| 05/01/2003 | WO2003035595A1 Novel norbornane and norbornene derivatives, use thereof and perfumed products containing same. |
| 05/01/2003 | WO2003035057A1 Inhibitors of dipeptidyl peptidase iv |
| 05/01/2003 | WO2002044113A9 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 05/01/2003 | US20030083523 Amide derivatives |
| 05/01/2003 | US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives |
| 05/01/2003 | US20030083382 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
| 05/01/2003 | US20030083359 Treating pain, urinary incontinence and bladder overactivity; P2X receptors are cation-permeable ion channels |
| 05/01/2003 | US20030083357 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia |
| 05/01/2003 | US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 05/01/2003 | US20030083332 N-heterocyclic derivatives as NOS inhibitors |
| 05/01/2003 | US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease |
| 05/01/2003 | US20030082831 Apparatus for use in the synthesis of preferential biopolymers |
| 05/01/2003 | US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity |
| 05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
| 04/30/2003 | CN1414956A Substituted piperazine derivatives as MIP inhibitors |
| 04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
| 04/30/2003 | CN1413992A 5-methylene-1,3,-dioxolane-4-one inducer, doubling body, chemical amplification type anti-corrosion composition and forming method |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/29/2003 | US6555690 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/29/2003 | US6555577 Compounds, their preparation and use |
| 04/24/2003 | WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | WO2002079124A3 Method of producing high yield alditol acetals with mineral acids and surfactants |
| 04/24/2003 | US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases |
| 04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand |
| 04/23/2003 | CN1412185A Production method of halogenated hexahydroxydiphenic derivative and its medicinal application |
| 04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 04/23/2003 | CN1106391C Magnolol series compounds and synthesizing process thereof, and medicinal composition using same as active component |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552080 Fungicidal compounds having a fluorovinyl-or fluoropropenyl-oxyphenyloxime moiety and process for the preparation thereof |
| 04/22/2003 | US6552023 Aralkyl substituted piperazine compounds |
| 04/17/2003 | WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 04/17/2003 | WO2003030909A1 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
| 04/17/2003 | US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents |
| 04/17/2003 | US20030073847 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 04/17/2003 | US20030073745 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias |
| 04/17/2003 | US20030073712 Antiinflamamtory agents; antiischemic agents |
| 04/17/2003 | US20030073701 Succinoylamino heterocycles as inhibitors of a beta protein production |
| 04/17/2003 | US20030073680 Therapy for Tay-sach, Gaucher diseases |
| 04/17/2003 | US20030073669 N-heterocyclic derivatives as NOS inhibitors |
| 04/16/2003 | EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 04/16/2003 | EP1301467A2 9-substituted minocycline compounds |
| 04/16/2003 | EP1301466A2 7-substituted tetracycline compounds |
| 04/16/2003 | EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/16/2003 | EP1301458A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 04/16/2003 | EP1119561B1 Process for the preparation of alkylene carbonate |
| 04/16/2003 | EP1040095B1 Cyclohexene carboxylates as neuraminidase inhibitors |
| 04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 04/16/2003 | CN1411374A Substituted piperazine and piperidine calcium channel blockers |
| 04/15/2003 | US6548694 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 04/15/2003 | US6548681 Acetalization and cyclization of aldehyde or ketone with polyol; separation, hydrolysis |